Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,744 | 31,533 | 24,310 | 32,823 | 43,894 |
| Marketable Securities | 61,598 | 53,535 | 69,712 | 72,795 | 70,115 |
| Receivables | 1,170 | 2,307 | 3,162 | 3,175 | 3,423 |
| TOTAL | $84,365 | $88,851 | $99,079 | $110,969 | $120,280 |
| Non-Current Assets | |||||
| PPE Net | 5,086 | 5,462 | 6,111 | 6,699 | 7,478 |
| Intangibles | 48,690 | 48,690 | 48,690 | 48,690 | 48,690 |
| Other Non-Current Assets | 4,103 | 4,574 | 1,929 | 1,929 | 1,929 |
| TOTAL | $57,879 | $58,726 | $56,730 | $57,318 | $58,097 |
| Total Assets | $142,244 | $147,577 | $155,809 | $168,287 | $178,377 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 4,926 | 4,784 |
| Accounts payable and accrued liabilities | 1,016 | 1,105 | 1,069 | 2,311 | 2,942 |
| Accrued Expenses | 5,410 | 5,474 | 7,007 | 9,614 | 12,256 |
| Other current liabilities | 2,545 | 2,777 | 4,526 | N/A | N/A |
| TOTAL | $11,509 | $11,989 | $12,602 | $16,851 | $19,982 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 21,109 | 22,895 | 19,147 | 23,302 | 30,348 |
| TOTAL | $21,109 | $22,895 | $19,147 | $23,302 | $30,348 |
| Total Liabilities | $32,618 | $34,884 | $31,749 | $40,153 | $50,330 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,019 | 13,769 | 12,440 | 11,503 | 10,835 |
| Common Shares | 15 | 13 | 12 | 169 | 157 |
| Retained earnings | -991,456 | -979,677 | -962,438 | -953,036 | -945,792 |
| Other shareholders' equity | 2,638 | 2,602 | 2,583 | 2,582 | 2,590 |
| TOTAL | $109,626 | $112,693 | $124,060 | $128,134 | $128,047 |
| Total Liabilities And Equity | $142,244 | $147,577 | $155,809 | $168,287 | $178,377 |